Now in its seventh consecutive year, HSCI’s Seed Grant Program provides two years of critical early funding (totaling $180,000) to scientists — often, but not exclusively, junior faculty —throughout the HSCI community who are engaged in stem cell research. Highest priority is given to investigators engaged in projects that would be difficult to fund from other sources because they are early stage, high risk, or lack sufficient preliminary data. This year, for the first time, HSCI had a separate category for translational awards.
In April, award notifications for 10 Seed Grants totaling $1.8 million were sent to the following investigators, who were selected from a pool of many highly qualified applicants.
· Elliot Chaikof, MD, PhD, Beth Israel Deaconess Medical Center
· Wolfram Goessling, MD, PhD, Brigham and Women’s Hospital
· Rakesh Karmacharya, MD, PhD, McLean Hospital
· Carla Kim, PhD, Children’s Hospital Boston
· Jordan Kreidberg, MD, PhD, Children’s Hospital Boston
· Eric Liao, MD, PhD, Massachusetts General Hospital
· Sandra McAllister, PhD, Brigham and Women’s Hospital
· Stanley Shaw, MD, PhD, Massachusetts General Hospital
· Joy Wu, MD, PhD, Massachusetts General Hospital
· Xu Wu, PhD, Massachusetts General Hospital